Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;10(3):109-124.
doi: 10.1007/s40124-022-00265-0. Epub 2022 Jun 22.

Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

Mariangela Soberón Felín  1 Kanix Wang  2 Catalina Raggi  3   4   5   6   7   8 Aliya Moreira  3   7   8 Abhinav Pandey  6   7   8 Andrew Grose  3 Zuleima Caballero  4 Claudia Rengifo-Herrera  9 Margarita Ramirez  6   7   8 Davina Moossazadeh  7   8   10 Catherine Castro  3   6 José Luis Sanchez Montalvo  6   7 Karen Leahy  3 Ying Zhou  3 Fatima Alibana Clouser  3 Maryam Siddiqui  3 Nicole Leong  3 Perpetua Goodall  3 Morgan Michalowski  3 Mahmoud Ismail  3 Monica Christmas  3 Stephen Schrantz  3 Ximena Norero  5 Dora Estripeaut  5 David Ellis  5 Kevin Ashi  3 Samantha Dovgin  6   7 Ashtyn Dixon  6 Xuan Li  11 Ian Begeman  3   6 Sharon Heichman  3   6 Joseph Lykins  3   6 Delba Villalobos-Cerrud  4 Lorena Fabrega  4 Connie Mendivil  4 Mario R Quijada  4 Silvia Fernández-Pirla  1   12 Valli de La Guardia  4 Digna Wong  4 Mayrene de LadrónGuevara  4 Carlos Flores  13 Jovanna Borace  13 Anabel García  4 Natividad Caballero  14 Maria Theresa Moreno de Saez  5 Michael Politis  1 Stephanie Ross  11 Mimansa Dogra  6 Vishan Dhamsania  3   15 Nicholas Graves  3   15 Marci Kirchberg  15   16 Kopal Mathur  15   16 Ashley Aue  16 Carlos M Restrepo  4 Alejandro Llanes  4 German Guzman  4 Arturo Rebollon  17 Kenneth Boyer  11 Peter Heydemann  11 A Gwendolyn Noble  6   18 Charles Swisher  18 Peter Rabiah  19 Shawn Withers  6 Teri Hull  3 Chunlei Su  20 Michael Blair  3   6 Paul Latkany  6 Ernest Mui  6 Daniel Vitor Vasconcelos-Santos  21 Alcibiades Villareal  4 Ambar Perez  4 Carlos Andrés Naranjo Galvis  22 Mónica Vargas Montes  23 Nestor Ivan Cardona Perez  23 Morgan Ramirez  7 Cy Chittenden  7 Edward Wang  7 Laura Lorena Garcia-López  23 Juliana Muñoz-Ortiz  24 Nicolás Rivera-Valdivia  24 María Cristina Bohorquez-Granados  24 Gabriela Castaño de-la-Torre  24 Guillermo Padrieu  25 Juan David Valencia Hernandez  24 Daniel Celis-Giraldo  24 John Alejandro Acosta Dávila  24 Elizabeth Torres  24 Manuela Mejia Oquendo  24 José Y Arteaga-Rivera  24 Dan Nicolae  10 Andrey Rzhetsky  2 Nancy Roizen  3 Eileen Stillwaggon  26 Larry Sawers  27 Francois Peyron  28 Martine Wallon  28 Emanuelle Chapey  28 Pauline Levigne  28 Carmen Charter  13 Migdalia De Frias  13 Jose Montoya  29 Cindy Press  29 Raymund Ramirez  29 Despina Contopoulos-Ioannidis  30 Yvonne Maldonado  30 Oliver Liesenfeld  31 Carlos Gomez  26 Kelsey Wheeler  6 Ellen Holfels  3 David Frim  3 David McLone  18 Richard Penn  3 William Cohen  3 Samantha Zehar  18 James McAuley  6 Denis Limonne  32 Sandrine Houze  33 Sylvie Abraham  33 Raphael Piarroux  32 Vera Tesic  3 Kathleen Beavis  3 Ana Abeleda  3 Mari Sautter  3 Bouchra El Mansouri  34 Adlaoui El Bachir  34 Fatima Amarir  35 Kamal El Bissati  3   34 Alejandra de-la-Torre  24 Gabrielle Britton  4   36 Jorge Motta  37 Eduardo Ortega-Barria  37   38 Isabel Luz Romero  37 Paul Meier  3 Michael Grigg  39 Jorge Gómez-Marín  23 Jagannatha Rao Kosagisharaf  4 Xavier Sáez Llorens  5   36 Osvaldo Reyes  12   13   36 Rima McLeod  1   2   3   6   7   8   40   41
Affiliations

Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

Mariangela Soberón Felín et al. Curr Pediatr Rep. 2022 Sep.

Abstract

Purpose of review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia.

Recent findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies to Toxoplasma and risk factors, were reviewed.

Summary: Screening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasma antibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overall Toxoplasma seroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis and Toxoplasma infection.

Keywords: Incidence; Prevalence; Risk factors; Screening; Spatial epidemiology; Toxoplasma; Toxoplasmosis.

PubMed Disclaimer

Conflict of interest statement

Declarations Conflict of Interest The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Sample slides from presentation by Pandey, Moreira, Wang, Rzhetsky, McLeod et al. that details their studies in Panama. One component of their research was a study on the effectiveness of using digital media to teach pregnant women about congenital toxoplasmosis. Pandey and Moreira also created incidence and screening maps for toxoplasmosis in Panama; these maps were based on screening data, IgG/IgM test results, demographic data, and addresses from prenatal control charts. See Supplement for complete presentation
Fig. 2
Fig. 2
Dot and scatter hexbin maps based on Moreira and Pandey et al.’s data on relative screening frequencies of patients in the Ciudad de Panamá metropolitan region. In the top two maps, gray points represent patients not screened for toxoplasmosis, orange points represent patients positive for infection, and blue points represent seronegative patients. Across all four maps, major trends in screening and case frequency include higher frequency of screening from north (more rural) to south (more urban) and higher seropositivity rates along roads and waterways
Fig. 3
Fig. 3
Maps of screening rates for CT by corregimiento (township) at three different scales, based on Wang et al.’s findings and Moreira and Pandey et al.’s data. Screening rates were calculated using a Bayesian prior of Beta(254, 411). Average screening rate among the townships represented by the women with available data was 38.2%. Townships with much lower or higher than average screening rates are marked with white asterisks
Fig. 4
Fig. 4
Summary of maps from Figs. 2 and 3, along with a map of toxoplasma seroprevalence by corregimiento (township) at three different scales. Prevalence rates were calculated using a Bayesian prior of Beta(63, 191). Average prevalence of toxoplasmosis among the townships represented by the women with available data was 24.8%. The highest rates of toxoplasmosis were observed in three provinces, shown in very dark red in the highest-resolution map, from west to east: Curundú, Pueblo Nuevo, Pedregal
Fig. 5
Fig. 5
Summary of findings from Moossazadeh’s study of risk factors and development of a mathematical model for predicting highest-risk areas of Toxoplasma infection in Panama A A strong, but not significant, inverse relationship between highest level attained and screening compliance was found. B Rural-urban comparison showed that pregnant women in urban areas were more likely to be screened; the relationship was not significant. C Ages of IgM + women show that average age of educational; IgM positive women in both 2016–2017 studies was lower than the mean age of their cohorts (25.57 ± 9.03 cf. 27.28 ± 6.23 and 24.43 ± 7.24 cf. 26.59 ± 7.15, respectively). D T. gondii IgG seropositivity rates among pregnant women by maternal age, plotted with age centered around the mean. The curve represents the fit from the logistic regression of IgG status against age squared, with age centered around its mean. The points are shaded according to the number of women at each age, where darker colors signify a greater number of women. E Average education level among pregnant women by maternal age, plotted with age centered around the mean. F T. gondii IgG seropositivity rates among pregnant women by education level. Error bars represent the standard error of the mean. G T. gondii IgG seropositivity rates among pregnant women by longitude. Zero degree represents the longitude of Hospital Santo Tomás. H IgG seropositivity rate based on contact or no contact with dogs (both in the street or as pets). Error bars represent the standard error of the mean
Fig. 6
Fig. 6
Summary of Raggi’s spatial epidemiological study of toxoplasma screening and seroprevalence rates in Panama. A KDE of previously screened individuals in the province of Panamá (n = 88). B KDE of previously unscreened individuals in the province of Panamá (n = 190). C KDE of previously screened individuals in Panamá Oeste (n = 60). D KDE of previously unscreened individuals in Panamá Oeste (n = 70). E KDE of positive IgG points in the province of Panamá (n = 83). F Aggregated toxoplasmosis prevalence rates based on Panama’s corregimientos, overlaid on Panama’s water systems
Fig. 7
Fig. 7
Summary of mapping studies from Colombia. A Scatterplot matrix of all variables used in the Armenia study. B Statistically significant variable relationships and their p value ranges for the entire population surveyed. C Heat map showing the distribution of all cases of CT that went untreated in Quindío (n = 23). D Heat map showing cases of CT that received prenatal treatment in Quindío (n = 21). E Heat map of relative frequencies of cats negative for Toxoplasma, as determined by the University of Quindío (n = 109). F Heat map of relative frequency of cats positive for Toxoplasma, as determined by the University of Quindío (n = 25)

References

    1. McLeod R, Lykins J, Noble AG, Rabiah P, Swisher C, Heydemann P, McLone D, Frim D, Withers S, Clouser F, Boyer K. Management of congenital toxoplasmosis. Curr Ped Rep. 2014;2(3):166–94.

      Describes presentation of congenital toxoplasmosis and approach to management of the disease in the United States, including definition of known risk factors, epidemiology, and care.

    1. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104:320–44. - PMC - PubMed
    1. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501–8. - PMC - PubMed
    1. Sousa OE, Saenz RE, Frenkel JK. Toxoplasmosis in Panama: a 10-year study. Am J Trop Med Hyg. 1988;38(2):315–22.

      Provides an early description of epidemiology of Toxoplasma infection in Panama.

    1. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J for Parasitol. 2009;39:1385–94. - PubMed

LinkOut - more resources